Showing results (81-90 of 896) with videos related to

Sort By:
Pageof 90
British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.
British Journal of Clinical Pharmacology|February 1, 1990
99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitroI Virgolini, P Angelberger, C Müller, et al.
Family Practice|March 27, 2001
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate casesA Lucassen, E Watson, J Harcourt, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Isradipine improves platelet function in hypertensivesH Sinzinger, I Virgolini, F Rauscha, et al.
Thrombosis Research|June 1, 1997
Effect of isradipine on in-vivo platelet functionJ O'Grady, H Kritz, P Schmid, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|March 1, 1994
Isradipine inhibits mitotic and proliferative activity in the arterial wallP Fitscha, F Rauscha, J O'Grady, et al.
Journal of Drug Targeting|January 1, 1993
The distribution of free and non-ionic vesicular sodium stibogluconate in the dogM Collins, K C Carter, A J Baillie, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1989
Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trialI Virgolini, P Fitscha, J O'Grady, et al.
Thrombosis Research|January 15, 1996
Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infectionC Pirich, Y Efthimiou, J O'Grady, et al.
Developments in Biological Standardization|January 1, 1996
Virus removal studies using nanofiltration membranesJ O'Grady, A Losikoff, J Poiley, et al.
Pageof 90